Tecovirimat is an antiviral pharmaceutical raw material. It is a small-molecule compound that inhibits orthopoxvirus replication by blocking the release of virus particles from infected cells.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 816458-31-8
Tecovirimat
pharmaceutical raw material
Tecovirimat monohydrate
pharmaceutical raw material
Bambuterol hydrochloride
pharmaceutical raw material
(S)-1-(2,6-Dimethylphenoxy)propan-2-amine hydrochloride
pharmaceutical raw material
2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone
pharmaceutical raw material
Treprostinil
pharmaceutical raw material
N-[(1R,2R,6S,7S,8S,10R)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide
CSKDFZIMJXRJGH-VWLPUNTISA-N
C1[C@@H]2[C@H]1[C@@H]3C=C[C@H]2[C@@H]4[C@H]3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F